Post-effective Amendment to an S-8 Filing (s-8 Pos)
November 04 2013 - 5:00PM
Edgar (US Regulatory)
As filed with the Securities and Exchange
Commission on November 4, 2013
Registration No.
333-180139
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT
NO. 1
TO
FORM S-8 REGISTRATION STATEMENT NO. 333-180139
UNDER
THE SECURITIES ACT OF 1933
GREENWAY MEDICAL TECHNOLOGIES, INC.
(Exact name of registrant
as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
|
58-2412516
I.R.S. Employer
Identification No.)
|
100 Greenway Boulevard
Carrollton, GA 30117
(770) 836-3100
(Address of Principal Executive Offices)(Zip Code)
Greenway Medical Technologies, Inc. 1999
Stock Option Plan
Greenway Medical Technologies, Inc. 2004
Stock Plan
Greenway Medical Technologies, Inc. 2011
Stock Plan
(Full titles of the plans)
James A. Cochran
Chief Financial Officer
Greenway Medical Technologies, Inc.
100 Greenway Boulevard
Carrollton, GA 30117
(770) 836-3100
(Name, address, and telephone number of agent for service)
Copy to:
Reinaldo Pascual
Paul Hastings LLP
1170 Peachtree Street, N.E., Suite 100
Atlanta, GA 30309
(404) 815-2227
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions
of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2
of the Exchange Act.
Large accelerated filer
£
|
|
Accelerated filer
S
|
Non-accelerated filer (Do not check if a smaller reporting company)
£
|
|
Smaller reporting company
£
|
|
|
|
DEREGISTRATION OF SECURITIES
This post-effective amendment (the “Post-Effective
Amendment”), filed by Greenway Medical Technologies, Inc., a Delaware corporation (the “Company”), to remove
from registration all shares of common stock, par value $0.0001 per share, of the Company (the “Shares”) registered
under Registration Statement No. 333-180139 on Form S-8, filed by the Company filed on March 15, 2012 (the “Registration
Statement”) with the U.S. Securities and Exchange Commission (the “SEC”), pertaining to the registration of the
Shares offered under (i) Greenway Medical Technologies, Inc. 1999 Stock Option Plan, (ii) Greenway Medical Technologies, Inc. 2004
Stock Plan and (iii) Greenway Medical Technologies, Inc. 2011 Stock Plan.
On September 23, 2013, the Company
entered
into an Agreement and Plan of Merger with VCG Holdings, LLC, a Delaware limited liability company (“Parent”), and Crestview
Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”)
, providing
for, among other things, the merger of Merger Sub with and into the Company (the “Merger”), with the Company continuing
as the surviving corporation and a direct wholly-owned subsidiary of Parent. The Merger became effective at 8:14 a.m., New York
City Time, on November 4, 2013, pursuant to the Certificate of Ownership and Merger filed with the Secretary of State of the State
of Delaware.
As a result of the Merger, the Company has terminated
all offerings of its Shares pursuant to the Registration Statement. In accordance with an undertaking made by the Company in the
Registration Statements to remove from registration, by means of a post-effective amendment, any Shares which remain unsold at
the termination of the offering, the Company hereby removes from registration all Shares registered under the Registration Statements
that remain unsold as of the date of the Post-Effective Amendments and terminates the effectiveness of the Registration Statements.
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, as amended, the Registrant has duly caused this Registration Statement on Form S-8 to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Carrollton, State of Georgia, on the 4th day of November, 2013.
|
Greenway Medical Technologies, Inc.
|
|
|
|
By:
|
/s/ William G. Esslinger, Jr.
|
|
|
Name: William G. Esslinger, Jr.
Title: Vice President, General Counsel and Secretary
|
Note: No other person is required to sign this
Post-Effective Amendment in reliance upon Rule 478 under the Securities Act of 1933, as amended.
Greenway Medical Technologies Com USD0.0001 (NYSE:GWAY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Greenway Medical Technologies Com USD0.0001 (NYSE:GWAY)
Historical Stock Chart
From Jul 2023 to Jul 2024